These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 22497792)

  • 1. Risk stratification of patients with IgA nephropathy.
    Barbour SJ; Reich HN
    Am J Kidney Dis; 2012 Jun; 59(6):865-73. PubMed ID: 22497792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of outcome in paediatric IgA nephropathy with regard to clinical and histopathological variables (Oxford classification).
    Edström Halling S; Söderberg MP; Berg UB
    Nephrol Dial Transplant; 2012 Feb; 27(2):715-22. PubMed ID: 21750154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors and therapy assessment of IgA nephropathy: report from a single unit in iran.
    Soleymanian T; Najafi I; Salimi BH; Broomand B
    Ren Fail; 2011; 33(6):572-7. PubMed ID: 21663387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population.
    Le W; Liang S; Hu Y; Deng K; Bao H; Zeng C; Liu Z
    Nephrol Dial Transplant; 2012 Apr; 27(4):1479-85. PubMed ID: 21965586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.
    Lv J; Zhang H; Zhou Y; Li G; Zou W; Wang H
    Nephrology (Carlton); 2008 Jun; 13(3):242-6. PubMed ID: 18221258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgA nephropathy: the presence of familial disease does not confer an increased risk for progression.
    Izzi C; Ravani P; Torres D; Prati E; Viola BF; Guerini S; Foramitti M; Frascà G; Amoroso A; Ghiggeri GM; Schena FP; Scolari F
    Am J Kidney Dis; 2006 May; 47(5):761-9. PubMed ID: 16632014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting progression in IgA nephropathy.
    Bartosik LP; Lajoie G; Sugar L; Cattran DC
    Am J Kidney Dis; 2001 Oct; 38(4):728-35. PubMed ID: 11576875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A predictive clinical grading system for immunoglobulin A nephropathy by combining proteinuria and estimated glomerular filtration rate.
    Okonogi H; Utsunomiya Y; Miyazaki Y; Koike K; Hirano K; Tsuboi N; Suzuki T; Hara Y; Ogura M; Hosoya T; Kawamura T
    Nephron Clin Pract; 2011; 118(3):c292-300. PubMed ID: 21212693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors for progression in immunoglobulin A nephropathy with significant proteinuria.
    Hwang HS; Kim BS; Shin YS; Yoon HE; Song JC; Choi BS; Park CW; Yang CW; Kim YS; Bang BK
    Nephrology (Carlton); 2010 Mar; 15(2):236-41. PubMed ID: 20470285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The retrospective analysis of 343 Czech patients with IgA nephropathy--one centre experience.
    Maixnerova D; Bauerova L; Skibova J; Rysava R; Reiterova J; Merta M; Honsova E; Tesar V
    Nephrol Dial Transplant; 2012 Apr; 27(4):1492-8. PubMed ID: 21891776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of sex in primary glomerulonephritis.
    Cattran DC; Reich HN; Beanlands HJ; Miller JA; Scholey JW; Troyanov S;
    Nephrol Dial Transplant; 2008 Jul; 23(7):2247-53. PubMed ID: 18182409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tonsillectomy has beneficial effects on remission and progression of IgA nephropathy independent of steroid therapy.
    Maeda I; Hayashi T; Sato KK; Shibata MO; Hamada M; Kishida M; Kitabayashi C; Morikawa T; Okada N; Okumura M; Konishi M; Konishi Y; Endo G; Imanishi M
    Nephrol Dial Transplant; 2012 Jul; 27(7):2806-13. PubMed ID: 22492824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of cases of IgA nephropathy.
    World MJ
    J R Army Med Corps; 2013 Jun; 159(2):90-3. PubMed ID: 23720589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Point of no return (PNR)" in progressive IgA nephropathy: significance of blood pressure and proteinuria management up to PNR.
    Komatsu H; Fujimoto S; Sato Y; Hara S; Yamada K; Morita S; Eto T
    J Nephrol; 2005; 18(6):690-5. PubMed ID: 16358226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Oxford classification as a predictor of prognosis in patients with IgA nephropathy.
    Kang SH; Choi SR; Park HS; Lee JY; Sun IO; Hwang HS; Chung BH; Park CW; Yang CW; Kim YS; Choi YJ; Choi BS
    Nephrol Dial Transplant; 2012 Jan; 27(1):252-8. PubMed ID: 21606384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasculitic IgA nephropathy: prognosis and outcome.
    Pankhurst T; Lepenies J; Nightingale P; Howie AJ; Adu D; Harper L
    Nephron Clin Pract; 2009; 112(1):c16-24. PubMed ID: 19342865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
    Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S
    Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remission of proteinuria improves prognosis in IgA nephropathy.
    Reich HN; Troyanov S; Scholey JW; Cattran DC;
    J Am Soc Nephrol; 2007 Dec; 18(12):3177-83. PubMed ID: 17978307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study.
    Manno C; Strippoli GF; D'Altri C; Torres D; Rossini M; Schena FP
    Am J Kidney Dis; 2007 Jun; 49(6):763-75. PubMed ID: 17533019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A scoring system to predict renal outcome in IgA nephropathy: from a nationwide prospective study.
    Wakai K; Kawamura T; Endoh M; Kojima M; Tomino Y; Tamakoshi A; Ohno Y; Inaba Y; Sakai H
    Nephrol Dial Transplant; 2006 Oct; 21(10):2800-8. PubMed ID: 16822793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.